Recurrent Extrahepatic Bile Duct Cancer
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB01933 | 7-Hydroxystaurosporine | 1 | Completed | 1 |
DB00958 | Carboplatin | 1 | Completed | 1 |
DB00002 | Cetuximab | 1 | Completed | 1 |
DB15631 | Edodekin alfa | 1 | Completed | 1 |
DB00530 | Erlotinib | 1 | Completed | 1 |
DB00762 | Irinotecan | 1 | Completed | 1 |
DB15721 | Natural Killer Cell | 1 | Completed | 1 |
DB01229 | Paclitaxel | 1 | Completed | 1 |
DB00072 | Trastuzumab | 1 | Completed | 1 |
DB12109 | Devimistat | 1 / 2 | Completed | 1 |
DB00166 | Lipoic acid | 1 / 2 | Completed | 1 |
DB00112 | Bevacizumab | 2 | Completed | 1 |
DB00188 | Bortezomib | 2 | Terminated | 1 |
DB04849 | Cediranib | 2 | Terminated | 1 |
DB00530 | Erlotinib | 2 | Completed | 2 |
DB00544 | Fluorouracil | 2 | Terminated | 1 |
DB04845 | Ixabepilone | 2 | Terminated | 1 |
DB01259 | Lapatinib | 2 | Completed | 2 |
DB00650 | Leucovorin | 2 | Terminated | 1 |
DB00526 | Oxaliplatin | 2 | Terminated | 1 |
DB03010 | Patupilone | 2 | Terminated | 1 |
DB11689 | Selumetinib | 2 | Completed | 1 |
DB11689 | Selumetinib | 2 | Withdrawn | 1 |
DB00398 | Sorafenib | 2 | Completed | 1 |
DB00072 | Trastuzumab | 2 | Terminated | 1 |
DB00707 | Porfimer sodium | 3 | Withdrawn | 1 |
DB05296 | Motexafin lutetium | Not Available | Terminated | 1 |